The Latest Breaking News from FDA

The decision is the most impactful abortion ruling since the Supreme Court overturned Roe v. Wade.

WASHINGTON — A federal judge in Texas delivered a major blow to reproductive rights advocates Friday, ordering a hold on the U.S. Food and Drug Administration approval of mifepristone, an abortion medication used in the United States since 2000.

The ruling from U.S. District Judge Matthew Kacsmaryk in Amarillo could potentially upend access to medication abortion nationwide.

Judge Matthew Kacsmaryk has placed a temporary stay on the FDA approval for mifepristone, used in medication abortions.

A federal judge in Texas has thrown into jeopardy the most common method of abortion in the U.S., ordering regulators to temporarily halt their approval of the drug mifepristone for abortion

A federal judge in Texas will halt the FDA’s approval of mifepristone in seven days unless an appeals court intervenes. But the decision was quickly contradicted by a separate ruling, setting up more legal challenges

Two federal judges issued dueling opinions Friday over the FDA's approval of an abortion drug more than 20 years ago.

Exclusive: Pharmaceutical firm says groundbreaking jabs could save millions of lives

BEYOND BEAUTY CHANNEL BY DR. NIDA

A bill in the California Legislature would ban five chemicals found in some of the most popular candy in the U.S. The bill by Assemblymember Jesse Gabriel would ban chemicals found in candy like Skittles, Starbursts and Peeps

The U.S. Food and Drug Administration finalized a regulation in early March 2023 that updates mammography reporting requirements. The new regulation goes into effect on Sept. 10, 2024, and will require that all women receive information about breast density following a mammogram. It will also require they be told in…